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Abstract
 
The mechanism by which immature B cells are sequestered from encountering foreign antigens
present in lymph nodes or sites of inflammation, before their final maturation in the spleen, has
not been elucidated. We show here that immature B cells fail to home to the lymph nodes.
These cells can actively exclude themselves from antigen-enriched sites by downregulating
their integrin-mediated adhesion to the extracellular matrix protein, fibronectin. This inhibi-
 
tion is mediated by interferon 
 
g 
 
secretion. Perturbation of interferon 
 
g
 
 activity in vivo leads to
the homing of immature B cells to the lymph nodes. This is the first example of autocrine reg-
ulation of immune cell migration to sites of foreign antigen presentation.
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Introduction
 
B cells develop in the bone marrow and, through a process
that involves rearrangement and expression of Ig genes,
produce an antigen-specific receptor, which is first mani-
fested in the immature stage. Immature B cells emerge
from the bone marrow to the periphery and migrate into
the spleen for their final maturation step. This migration
proceeds through the terminal branches of central arteri-
oles to blood sinusoids of the marginal zone (1, 2). Newly
made B cells then penetrate the marginal zone sinus to end
up in the outer zone of the periarteriolar lymphocytic
sheath (3). At this site in the spleen, B cells are still imma-
ture and can be distinguished from their mature counter-
parts (1, 2, 4, 5).
One of the most fundamental and important aspects of
the immune system is its ability to recognize and respond
to virtually any foreign antigen while maintaining strict un-
responsiveness to self-antigens. For B cells, antigens en-
countered during the immature stage, at anatomic sites
populated with these cells, are likely to be self-antigens,
and therefore, reactive clones are eliminated. The selection
process occurring within the immature B cell compart-
ments is also extended to the periphery, allowing deletion
of all B cells recognizing peripheral self-antigens outside of
the bone marrow (1, 6, 7).
Immature B cells leave the bone marrow and migrate to
the spleen where they can mature before antigen encoun-
ter. Like other naive lymphocytes, before their arrival to
the spleen immature B cells might recirculate to nonsplenic
secondary lymphoid organs, which are specialized tissues
for collecting antigens (8), or to sites of infection and in-
flammation. In these secondary lymphoid organs, where
differentiation to mature cells does not occur, antigen en-
counter would lead to the death of the immature B cells
and elimination of effective clones due to the negative se-
lection process. Although recently it was suggested that
CD40 signaling can induce immature B cell responsiveness
to multiple members of the 
 
g
 
 chain–common cytokine
family (9), physiological stimulation of immature cells is
known to usually lead to an arrest of cell differentiation and
clonal deletion (1, 6, 7). In this work, we postulated the
existence of biological mechanisms to prevent immature B
cells from reaching antigen-enriched sites before matura-
tion.
Herein we show that by autocrine secretion of IFN-
 
g
 
, B
cells developmentally regulate their recruitment to LNs.
 
Materials and Methods
 
Cells.
 
Cells were obtained from control C57BL/6, invariant
 
chain (Ii)
 
2
 
/
 
2
 
 (10), or IFN-
 
g
 
–deficient mice on C57BL/6 back-
ground (The Jackson Laboratory) at 6–8 wk of age. Spleen and
LN cells were purified as described previously (10).
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Separation of B Cells.
 
B cells were purified by treating the
splenocyte suspension with anti–Thy 1.2, CD4, and CD8 (South-
ern Biotechnology Associates, Inc.), followed by low Tox-M
complement (Cedarlane). To separate between the control IgD
 
2
 
cells from the IgD
 
1
 
 population, we used the MACS system
(Miltenyi Biotec). The IgD
 
2
 
 population was incubated with anti-
CD45RA (B220) magnetic beads and reseparated using the
MACS system. For comparison of populations, in those experi-
ments in which the control immature B cell population was sepa-
rated, the Ii
 
2
 
/
 
2
 
 B cells were purified by the MACS system using
the CD45RA beads. T cells were obtained by collecting the
B220
 
2
 
 population. To separate between the IgD
 
2
 
CD21
 
1
 
 and
IgD
 
2
 
CD21
 
2
 
 populations, IgD
 
2
 
 cells were divided according
to their CD21 expression using the MACS system. The
IgD
 
2
 
CD21
 
2
 
 cells were incubated with anti-CD45RA magnetic
beads and reseparated. The purity of each cell population was de-
termined by flow cytometry.
 
Immunofluorescence Staining.
 
The following antibodies used in
the experiments were purchased from BD PharMingen: 14.8
anti-CD45RA, B3b4 anti-CD23, 7G6 anti-CD21/CD35, R6-
60.2 anti-IgM, AMS 9.1 anti-IgD, 7G6 anti-CD21/CD35,
MEL-14 anti–L-selectin, R1-2 anti–very late antigen (VLA)-4,
5H10-27 anti–VLA-5, 2D7 anti–LFA-1, and anti-
 
a
 
4.
 
Adhesion Assay.
 
Adhesion assays were performed as described
previously (11). 96-well plates were coated with fibronectin (100
 
m
 
g/ml). 
 
51
 
Cr-labeled cells (2 
 
3
 
 10
 
5
 
/well) were suspended in
RPMI supplemented with 0.1% FCS or conditioned medium
collected from control or Ii
 
2
 
/
 
2 
 
cells. The cells were plated in each
coated well, in the presence or absence of LPS (10 
 
m
 
g/ml), PMA
(0.25 
 
m
 
g/ml), IL-2 (0.2 U/
 
m
 
l), stromal cell–derived factor
(SDF)-1 (1 
 
m
 
g/ml), EDTA (5 mM), or LDV- and RGD-con-
taining peptides (800 
 
m
 
g/ml). After 30 min, plates were washed.
The adherent cells were lysed and the radioactivity was deter-
mined. Results were expressed as the mean percentage (
 
6 
 
SD) of
bound cells from quadruplicate wells. The percentage of cells that
adhered was calculated as follows: (total counts of residual cells in
the well)/(total counts of cells added to the well) 
 
3 
 
100.
 
RNA Isolation and Reverse Transcription.
 
Total RNA was iso-
lated from cells using the TRI reagent kit (Molecular Research
Center). Reverse transcription was carried out using Superscript
II RT (GIBCO BRL). The primers and PCR conditions were as
described previously (12).
 
Detection of IFN-
 
g
 
.
 
Cells were lysed as described previously
(10). IFN-
 
g
 
 was immunoprecipitated by overnight incubation
with the R4-6A2 monoclonal antibody to IFN-
 
g
 
 (BD PharMin-
gen) followed by protein G–Sepharose beads (Amersham Phar-
Figure 1. Cytofluorometric analysis of B cells from spleen and LNs and
their maturation markers. (A) Control and Ii2/2 splenocytes or pooled
LN cells were stained with anti-B220. Histograms show the percentage of
B cells in each population. (B) Splenocytes and LN cells were triple
stained with anti-B220, anti-IgM, and anti-IgD. FACS® analysis demon-
strates the expression of IgM and IgD on B2201-gated cells. Boxes mark
the immature IgDlow population. (C) Dot plots show CD21 expression on
B2201 cells. (D) L-selectin expression on B cells. Control and Ii2/2 total
splenoytes were double stained with anti-B220 and anti–L-selectin. His-
tograms show the expression of L-selectin on B2201 cells. The differ-
ences between B and C in IgD expression pattern are not significant and
result from normal experimental errors. The percentage of this population
in both experiments falls in the standard deviation.
 
Table I.
 
Total Spleen Cell Number and the Percentage of the B 
Cell Population and the Mature (IgD
 
1
 
) and Immature (IgD
 
2
 
) 
Subpopulations in Control and Ii
 
2
 
/
 
2
 
 Mice
 
Control Ii
 
2
 
/
 
2
 
Spleen
Total cells 9.3 
 
6
 
 2 
 
3 
 
10
 
7
 
6 
 
6 
 
1.6 
 
3
 
 10
 
7
 
Percent B cells 46.5 
 
6 
 
8.2 47 
 
6 
 
10.2
Percent IgD
 
1
 
39.5 2.2
Percent IgD
 
2
 
6.8 44.5
LNs
Percent B cells 36 
 
6 
 
3 15 
 
6 
 
4
Percent IgD
 
1
 
35 13.3
Percent IgD
 
2
 
1 1.6 
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bronectin (30 
 
m
 
g/ml; Sigma-Aldrich) in the presence or absence
of SDF-1 (0.5 
 
m
 
g/ml). These plastic plates were assembled to
form the lower wall in a parallel wall flow chamber as described
previously (13). Cells were allowed to settle in the coated capil-
lary tube for 2 min before being subjected to increasing laminar
flow. Cell images were videotaped and manually quantitated by
analysis of images directly from the monitor screen.
 
Cytokine Concentration.
 
Cytokines (GIBCO BRL) were
added to the adhesion assay at the following concentrations: IL-4
(10
 
3 
 
U/ml), IL-5 (16 U/ml), IL-6 (16 U/ml), IL-12 (3.5 ng/ml),
and IFN-
 
g
 
 (0.1 U/ml).
 
Results and Discussion
 
To determine whether immature B cells are indeed ex-
cluded from secondary lymphoid organs while recirculating
through the body, we first compared the B cell distribution
Figure 2. Immature B cells do not increase their long-term integrin-mediated adhesion response to stimulation, although they have a normal short-
term response. (A) Wild-type mature B cells (B con) or immature B cells from Ii2/2 mice (B 2/2Ii) were labeled with 51Cr, washed, resuspended in
adhesion medium, and added to fibronectin-coated wells in the presence of PMA, LPS, SDF-1, or IL-2 stimulation. The adherent cells were lysed and
radioactivity was determined. One experiment representative of five is depicted. (B) Control B cells were 51Cr-labeled and tested for adhesion in the
presence or absence of PMA, EDTA (5 mM), LDV, or RGD (800 mg/ml). (C) Mature IgD1 B cells from control mice (B mature con), immature Ii2/2
B cells (B 2/2Ii), and immature IgD2 B cells from control mice (B imm con) were 51Cr-labeled and tested for adhesion. One experiment representative
of three is depicted. (D) Cytofluorometric analysis of integrin expression on immature and mature B cells. Control and Ii2/2 splenocytes were double
stained with anti-B220 and anti–VLA-4, VLA-5, LFA-1, or a4b7. Histograms show an overlay of the expression levels of the different integrins on con-
trol (light) and Ii2/2 (dark) B cells. (E) Resistance to shear stress by mature and immature B cells on fibronectin in a short-term adhesion assay. Control
(con) and Ii2/2 (2/2) B cells were allowed to attach to plates coated with fibronectin, alone or coimmobilized with SDF-1 (sdf). After attachment, flow
was initiated and increased in 2–2.5-fold increments every 10 s. The number of cells remaining bound at each interval was determined and is expressed as
the percentage of input cells remaining bound. The data depict one experiment representative of three.
 
macia Biotech). Lysates or immunoprecipitated proteins were
separated by 12% (wt/vol) SDS-PAGE. The proteins were trans-
ferred onto nitrocellulose and probed with the R4-6A2 anti–
IFN-
 
g
 
 antibody (BD PharMingen), followed by horseradish per-
oxidase–conjugated goat anti–rat IgG (Jackson ImmunoResearch
Laboratories).
 
Tracking of Cells In Vivo.
 
Cells were incubated for 30 min
with various treatments. The cells were then washed and labeled
for 30 min with the fluorescent marker BCECF-AM (10 
 
m
 
g/ml;
Molecular Probes; z97% of cells were stained). 5 3 107 washed
cells were injected intravenously into C57BL/6 mice in dupli-
cates. After 3.5 h, spleen and LNs were removed, and the per-
centage of fluorescent cells in both organs was analyzed by
FACS®. Inhibition of cell accumulation was calculated as: 100% 2
(the amount of cells present after treatment/the cells present in
the control mice). The results presented are the average of three
different experiments.
Laminar Flow Assay. Polystyrene plates were coated with fi-1384 IFN-g Regulates Homing of Immature B Cells
in spleen and LNs in control and in Ii–deficient (Ii2/2)
mice. B cells from Ii2/2 mice are arrested at an immature
stage and have an immature phenotype expressing low lev-
els of IgD and CD23 and partial CD21 expression (14–16;
Fig. 1, B and C, and Table I). Moreover, these Ii2/2 B cells
proliferate in response to LPS stimulation, but anti-IgM
causes their death (data not shown). However, control and
Ii2/2-derived B cells found in the LNs were enriched for
cells expressing a more mature phenotype, higher levels of
IgD. Moreover, as was described previously, in Ii2/2 mice
there was a striking decrease in the proportion of B cells
populating the LNs (15–17; Fig. 1 and Table I). These ob-
servations confirm that immature B cells are depleted from
the LNs, although the Ii2/2 population expresses significant
levels of L-selectin on their cell surface (Fig. 1 D).
To migrate to the LNs, leukocytes, including B cells,
must interact with adhesive components of the extracellular
matrix (ECM; 18). We therefore compared the adhesion
response of mature (control) and immature (Ii2/2) B sple-
nocytes by studying their ability to adhere, upon activation,
to fibronectin, a major ECM-based cell adhesive integrin
ligand. 51Cr-labeled B cells were plated for 30 min on fi-
bronectin-coated microtiter wells in the presence of PMA,
a potent agonist of integrin-mediated adhesion (19, 20),
LPS, a B cell mitogen, or SDF-1, a potent B cell chemoat-
tractant (21). After stimulation, control B cells dramatically
increased their adhesion to fibronectin. In contrast, the ad-
hesion of Ii2/2 immature B cells remained unchanged after
activation (Fig. 2 A). As expected, B cells did not respond
to stimulation with IL-2. The adhesion of B lymphocyte to
fibronectin in response to stimulation was abrogated in the
presence of the integrin inhibitor, EDTA, as well as by the
LDV and RGD peptides, selective blockers of VLA-4 and
VLA-5 (Fig. 2 B). Thus, the adhesion response observed
was integrin mediated.
The inability of Ii2/2 B cells to increase their adhesion to
fibronectin could be ascribed to the developmental stage of
the cells, or to Ii deficiency. Therefore, we compared the
adherence of purified control immature IgD2 and Ii2/2 B
cells in response to SDF-1 or PMA stimulation. Like im-
mature B cells derived from Ii2/2 mice, IgD2 immature B
cells from control mice were unable to respond to stimula-
tion and did not increase their adhesion to fibronectin (Fig.
2 C). Thus, the stage of maturity, and not the lack of Ii, de-
termined the response. Similar cell surface expression levels
of the integrins VLA-4, VLA-5, LFA-1, and a4, the major
fibronectin receptors, were detected on both Ii2/2 and
control B cells (Fig. 2 D). Thus, immature B cells possess
the adhesive molecules required for stimulation and adher-
ence to the ECM. To verify that intrinsic integrin function
is not impaired, we tested both control and Ii2/2 popula-
tions in a short-term adhesion assay on fibronectin-coated
surfaces assembled in a flow chamber apparatus. In the ab-
sence of stimulation, Ii2/2 B cells exhibited a slightly stron-
ger spontaneous adhesion to fibronectin than that of the
control cells. Surprisingly, rapid adhesion stimulation to fi-
Figure 3. Immature B cells and their conditioned medium inhibit the adhesion of
mature B cells. (A) 51Cr-labeled mature B cells (B con) were incubated with or
without labeled immature IgD2 B cells from Ii2/2 (B 2/2Ii) or control (Bimm)
mice in a 1:1 or 5:1 ratio in the presence or absence of stimulation. The cells were
tested for adhesion as described in the legend to Fig. 2. (B) 51Cr-labeled control B
cells were resuspended in the conditioned medium (sup) collected from control (B
con) or Ii2/2 (B 2/2Ii) B cells in the presence or absence of stimulation, and adhe-
sion was determined. One experiment representative of seven is depicted. (C) 51Cr-
labeled control B cells were resuspended in the conditioned medium (sup) collected
from control B cells (Bcon), Ii2/2 B (B 2/2Ii) unboiled or boiled, or immature
(Bimm) IgD2 control B cells in the presence or absence of stimulation (PMA), and
adhesion was determined.1385 Flaishon et al. Brief Definitive Report
bronectin was induced in both cell types by 2-min treat-
ment with SDF-1 (Fig. 2 E) or PMA (not shown). These
results indicate that both the expression of integrin recep-
tors for fibronectin and their ability to respond to rapid
stimulation are normal in immature B cells. Thus, the lack
of adhesion by immature cells during the 30-min adhesion
assay appeared to result from inhibitory events subsequent
to normal initial integrin-mediated adhesion.
To test whether the inhibition of adhesion may be trans-
ferred to other cells, we determined the ability of purified
wild-type IgD2 immature or Ii2/2 B cells to inhibit the ad-
hesion of purified mature IgD1 B cells when comixed.
Surprisingly, both the control IgD2 and Ii2/2 immature B
cells had an inhibitory effect on the adhesion of mature B
lymphocytes to fibronectin (Fig. 3 A); the inhibition could
be abrogated by fivefold dilution of the immature cells
within the mature population.
The inhibitory effect mediated by immature B cells
could be explained by direct cell–cell interaction, or by
secretion of a soluble inhibitory factor. To determine
whether a factor secreted from the cells could affect B cell
adhesion, we analyzed the activity of conditioned medium
collected from the cells. Wild-type or Ii2/2 immature B
cells were plated on fibronectin-coated microwells and 30
min later their conditioned medium was collected. The
ability of stimulated control B cells to adhere to fibronectin
in the presence of conditioned medium derived from con-
trol or Ii2/2 immature B cells was studied. Whereas condi-
tioned medium collected from control B cells did not affect
cell adhesion, cells incubated with conditioned medium
collected from Ii2/2 B cells (Fig 3, B and C) or control
IgD2 immature B cells (Fig. 3 C) maintained a low adhe-
sion response after stimulation. Thus, the conditioned me-
dium derived from immature B cells contained a factor(s)
that inhibited the adhesion of stimulated B cells. The factor
was heat sensitive (Fig. 3 C).
To determine the identity of this factor, various cyto-
kines were screened for their ability to suppress agonist-
stimulated B cell adhesion to fibronectin. Of the chemokines
tested, only IFN-g could mimic the effect of the condi-
labeled mature B cells were incubated with PMA. The adhesion response of the cells was designated as 100%. The adhesion response of these cells incu-
bated in conditioned medium derived from Ii2/2 immature B cells (sup) itself or conditioned medium treated overnight with rat anti–mouse IgG (ram)
or rat anti–IFN-g (a-IFN) antibodies was calculated as a percentage of the PMA response. (D) Reverse transcription PCR was performed as described in
Materials and Methods. (E) Steady-state levels of IFN-g in total cell lysates of IgD2 B cells from control or Ii2/2 mice, mature IgD1 B and T cells from
control mice, or IFN-g immunoprecipitated from conditioned medium (sup) of control and Ii2/2 B cells. The band representing IFN-g is indicated.
Figure 4. IFN-g secreted by immature B cells negatively regulates adhe-
sion. (A) 51Cr-labeled mature B cells were incubated in the presence of
PMA with or without various cytokines or alternatively in conditioned me-
dium collected from immature B cells (sup) in the presence of PMA. The
adhesion of cells was determined as described in the legend to Fig. 2. (B)
51Cr-labeled mature B cells were incubated with PMA and various concen-
trations of recombinant IFN-g and their adhesion was determined. (C) 51Cr-1386 IFN-g Regulates Homing of Immature B Cells
tioned medium derived from immature B cells (Fig. 4 A),
and acted in a concentration-dependent manner (Fig. 4 B).
Antibodies against IFN-g partially blocked (z50%) the in-
hibitory effect of immature B cell–conditioned medium.
The partial nature of the antibody blocking may indicate
involvement of an additional factor(s) in this process (Fig. 4
C). Reverse transcription PCR analysis revealed that IFN-g
expression by immature B cells is developmentally regu-
lated at the transcriptional level. Although mRNA was de-
tected in both control and Ii2/2IgD2 immature B cells
(15–17; Fig. 1), this transcript was not found in IgD1 B
cells from control mice (Fig. 4 D). Furthermore, the low
partially mature IgD1 B cell population, which is present in
Ii2/2 mice, downregulated its IFN-g mRNA levels as well
(data not shown). Newly emigrant immature B cells can be
separated from the marginal zone cells by the expression of
the CD21 marker. To determine which population secretes
IFN-g, we analyzed IFN-g message in the CD211 and
CD212 IgD2 populations. As can be seen in Fig. 4 D, the
IFN-g mRNA can be detected in the IgD2CD212 cells
from both control and Ii2/2 mice. After acquisition of
CD21, the cells downregulate their IFN-g expression.
Thus, IFN-g is transcribed mostly in newly arrived imma-
ture B cells. The Western blot analysis of IFN-g expression
in B cells during maturation revealed maturation-depen-
dent regulation of IFN-g production and secretion.
Whereas immature (IgD2) B cells from control or Ii2/2
mice express high levels of IFN-g, mature (IgD1) cells pro-
duce lower IFN-g levels. Importantly, conditioned me-
dium derived from Ii2/2 cells contained significant levels of
IFN-g, indicating that the cytokine is both produced and
secreted by immature B cells (Fig. 4 E).
We further studied the effect of the conditioned medium
and IFN-g on the entry into LNs in vivo (Fig. 5 A). Con-
trol or Ii2/2 total splenocytes were preincubated in the
presence of fresh medium (Fig. 5 A, bars 1 and 2), IFN- g
(Fig. 5 A, bar 6), conditioned medium collected from con-
trol B cells (Fig. 5 A, bar 3) or from Ii2/2 B cells (Fig. 5 A,
bar 4), or conditioned medium collected from Ii2/2 imma-
ture B cells treated with anti–IFN-g (Fig. 5 A, bar 5). The
cells were then washed, labeled with the fluorescent dye
BCECF-AM, and an equal number of live cells was in-
jected intravenously into control mice. The proportion of
labeled cells recovered in the spleen and LNs was deter-
mined 3.5 h after injection. The extent of labeled cell accu-
mulation in the spleen was unaffected by the various pre-
treatments. In contrast, migration of Ii2/2 and of control
cells incubated with Ii2/2 conditioned medium or IFN-g
to the LNs was significantly decreased, whereas cells incu-
bated with conditioned medium derived from control B
cells or control medium exhibited a degree of migration
similar to untreated cells. When control cells were incu-
bated in Ii2/2 conditioned medium treated with antibodies
against IFN-g, the ability of this conditioned medium to
inhibit homing of the cells to the LNs was partially blocked
(z50%). In agreement with previous studies, our results
suggest that the entry of lymphocytes from the blood into
the spleen does not depend on integrin–fibronectin inter-
actions, whereas migration to peripheral LNs is critically
regulated by these adhesive interactions (22).
To determine the biological significance of our studies,
we analyzed the B cell profile in spleen and LNs of geneti-
cally IFN-g–deficient mice (IFN-g2/2). Although spleens
derived from IFN-g2/2 exhibited wild-type levels of im-
mature and mature B cells, there was a striking difference
in the profile of the B cell population in the LNs. LNs of
IFN-g2/2 were populated with significantly greater levels
of immature B cells compared with their control counter-
parts (Fig. 5 B). These results demonstrate the physiological
role of IFN-g in regulating the arrival of immature B cells
to the LNs.
En route to the spleen, for their final maturation, imma-
ture B cells recycle through the blood and can be recruited
either to LNs or to sites of inflammation. Immature B cells
prevent premature encounter with antigen by downregu-
lating their own migration into the LNs. This inhibition is
Figure 5. IFN-g regulates the mi-
gration and arrival of immature B
cells to the LNs in vivo. (A) Inhibi-
tion in the arrival of labeled cells to
spleen or LNs. The proportion of
control cells which homed to con-
trol spleen or LNs was designated
100%. The arrival of Ii2/2 cells or
control cells treated with condi-
tioned medium derived from control
(sup con) or Ii2/2 (sup 2/2Ii) B
cells or Ii2/2-conditioned media
treated with anti–IFN-g (sup 2/2Ii
a-IFN) or in the presence of IFN-g
(1 U/ml) was calculated as the per-
centage of control homing. Inhibi-
tion was defined as: 100% 2 the
percentage of cells arrived in each
treatment. The data shown represent
the average of three experiments.
(B) Analysis of spleen and LNs derived from control and IFN-g–deficient mice. Dot plots show the expression of the markers IgD and IgM on the total
spleen and LN cells. The percentage of the immature population out of the 100% of B cells is calculated. The data depict one mouse out of four analyzed.1387 Flaishon et al. Brief Definitive Report
mediated by IFN-g, which is transcribed and secreted by
immature B cells but dramatically downregulated in mature
B cells. Our in vivo results directly demonstrate the physio-
logical significance of IFN-g secretion in preventing im-
mature B cell arrival to sites of foreign antigen presentation.
In addition, low levels of IFN-g have the ability to regulate
the adhesion of mature B cells (23; Fig. 4). As immature B
cells normally migrate to specific microenvironments, and
the proportion of immature B cells in the circulation is
low, it is more likely that immature B cells use IFN-g to
locally influence their integrin function rather than to exert
global effects on mature B cells in vivo. The powerful in-
hibitory effect of IFN-g on adhesion of B lymphocytes
both in vitro and in vivo suggests that this protein if prop-
erly targeted may have therapeutic clinical application as a
B cell–specific antiinflammatory agent in addition to its
many other functions.
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